Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Apr 5;170(3):499–506. doi: 10.1007/s10549-018-4779-x

Table 1.

IC50 Concentration of Inhibitors

Inhibitor Cell Lines

MCF-7aro LET-R RAD-R
Erlotinib (EGFR) 1036nM 9375nM 2651nM
Everolimus (mTORC1) 250nM 2000nM 8000nM
Lapatinib (HER2) 1698nM 2148nM 389nM
MK-2206 (AKT) 90nM 80nM 22nM
MLN0128 (mTORC1/2) 5nM 10nM 50nM
Palbociclib (CDK4/6) 50nM 5000nM 10000nM
PPP (IGF1R) 69nM 103nM 84nM